236 related articles for article (PubMed ID: 23193911)
1. Antitumor properties of taxol in combination with cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian tumor growth in vivo.
Li W; Zhai L; Tang Y; Cai J; Liu M; Zhang J
Oncol Res; 2012; 20(2-3):49-59. PubMed ID: 23193911
[TBL] [Abstract][Full Text] [Related]
2. Effects of cyclooxygenase inhibitors in combination with taxol on expression of cyclin D1 and Ki-67 in a xenograft model of ovarian carcinoma.
Li W; Cai JH; Zhang J; Tang YX; Wan L
Int J Mol Sci; 2012; 13(8):9741-9753. PubMed ID: 22949827
[TBL] [Abstract][Full Text] [Related]
3. Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian carcinoma in vivo.
Li W; Wang J; Jiang HR; Xu XL; Zhang J; Liu ML; Zhai LY
Int J Mol Sci; 2011 Jan; 12(1):668-81. PubMed ID: 21340007
[TBL] [Abstract][Full Text] [Related]
4. Effects of combining Taxol and cyclooxygenase inhibitors on the angiogenesis and apoptosis in human ovarian cancer xenografts.
Li W; Tang YX; Wan L; Cai JH; Zhang J
Oncol Lett; 2013 Mar; 5(3):923-928. PubMed ID: 23426648
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
Wang L; Chen W; Xie X; He Y; Bai X
Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
[TBL] [Abstract][Full Text] [Related]
6. Effects of SC-560 in combination with cisplatin or taxol on angiogenesis in human ovarian cancer xenografts.
Li W; Wan L; Zhai LY; Wang J
Int J Mol Sci; 2014 Oct; 15(10):19265-80. PubMed ID: 25342321
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 expression and the inhibitory effect of celecoxib on ovarian tumor growth in vivo.
Li W; Jiang HR; Xu XL; Wang J; Zhang J; Liu ML; Zhai LY
Int J Mol Sci; 2010 Oct; 11(10):3999-4013. PubMed ID: 21152316
[TBL] [Abstract][Full Text] [Related]
8. Increase of cyclooxygenase-2 inhibition with celecoxib combined with 5-FU enhances tumor cell apoptosis and antitumor efficacy in a subcutaneous implantation tumor model of human colon cancer.
Zhang DQ; Guo Q; Zhu JH; Chen WC
World J Surg Oncol; 2013 Jan; 11():16. PubMed ID: 23347845
[TBL] [Abstract][Full Text] [Related]
9. Effects of a cyclooxygenase-1-selective inhibitor in a mouse model of ovarian cancer, administered alone or in combination with ibuprofen, a nonselective cyclooxygenase inhibitor.
Li W; Xu RJ; Lin ZY; Zhuo GC; Zhang HH
Med Oncol; 2009; 26(2):170-7. PubMed ID: 18988002
[TBL] [Abstract][Full Text] [Related]
10. Effect of the combination of a cyclooxygenase-1 selective inhibitor and taxol on proliferation, apoptosis and angiogenesis of ovarian cancer in vivo.
Li W; Liu ML; Cai JH; Tang YX; Zhai LY; Zhang J
Oncol Lett; 2012 Jul; 4(1):168-174. PubMed ID: 22807982
[TBL] [Abstract][Full Text] [Related]
11. Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum.
Ninomiya I; Nagai N; Oyama K; Hayashi H; Tajima H; Kitagawa H; Fushida S; Fujimura T; Ohta T
Oncol Rep; 2012 Sep; 28(3):777-84. PubMed ID: 22751903
[TBL] [Abstract][Full Text] [Related]
12. Effect of celecoxib combined with chemotherapy drug on malignant biological behaviors of gastric cancer.
Meng C; Lu Z; Fang M; Zhou X; Dai K; Zhang S; Luo J; Luo Z
Int J Clin Exp Pathol; 2014; 7(11):7622-32. PubMed ID: 25550798
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumoral effect of a celecoxib low dose on a model of human medullary thyroid cancer in nude mice.
Quidville V; Segond N; Tebbi A; Cohen R; Jullienne A; Lepoivre M; Lausson S
Thyroid; 2009 Jun; 19(6):613-21. PubMed ID: 19281427
[TBL] [Abstract][Full Text] [Related]
14. [Celecoxib induces apoptosis and inhibits angiogenesis in gastric cancer].
Ran JT; Zhou YN; Tang CW; Lu JR; Wu J; Lu H; Yang GD
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):448-51. PubMed ID: 19024521
[TBL] [Abstract][Full Text] [Related]
15. Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo.
Zhao Y; Hao Y; Ji H; Fang Y; Guo Y; Sha W; Zhou Y; Pang X; Southerland WM; Califano JA; Gu X
Cancer Prev Res (Phila); 2010 Jun; 3(6):787-96. PubMed ID: 20501859
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis.
Liu NB; Peng T; Pan C; Yao YY; Shen B; Leng J
World J Gastroenterol; 2005 Oct; 11(40):6281-7. PubMed ID: 16419156
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib inhibits meningioma tumor growth in a mouse xenograft model.
Ragel BT; Jensen RL; Gillespie DL; Prescott SM; Couldwell WT
Cancer; 2007 Feb; 109(3):588-97. PubMed ID: 17177201
[TBL] [Abstract][Full Text] [Related]
18. Effects of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of ovarian carcinoma in vivo.
Li W; Zhang HH; Xu RJ; Zhuo GC; Hu YQ; Li J
Med Oncol; 2008; 25(2):172-7. PubMed ID: 18488158
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats.
Rao CV; Steele VE; Swamy MV; Patlolla JM; Guruswamy S; Kopelovich L
Cancer Res; 2009 Oct; 69(20):8175-82. PubMed ID: 19826045
[TBL] [Abstract][Full Text] [Related]
20. Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2.
Park W; Oh YT; Han JH; Pyo H
J Exp Clin Cancer Res; 2008 Nov; 27(1):66. PubMed ID: 19000324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
